The ORCA-3 study is being conducted to learn more about the effectiveness and safety of an oral medicine, cytisinicline, in combination with behavioral support in people trying to quit cigarette smoking.
Precision Clinical Research's Dr. Jason Haffizulla sat down with WLPG Channel 10 HealthCast to discuss the clinical trial we are conducting (part of a large scale clinical trial) into a vaccine for respiratory syncytial virus, or RSV, for adults over the age of 60.